TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin’s lymphoma

Z-Z Yang, D M Grote, B Xiu, +6

Leukemia

Lymphoid NeoplasiaAdaptive Immune SystemImmune RegulationTumor ImmunityPathology +5

PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival

Zhengke Yang, D M Grote, S C Ziesmer, +3

Blood Cancer Journal

T-regulatory CellImmunologyPathologyCell DeathT Cells +17

IL-10 induces the development of immunosuppressive CD14+HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphoma

B Xiu, Yi Lin, D M Grote, +10

Blood Cancer Journal

Lymphocyte DevelopmentImmunologyPathologyImmune SystemImmunotherapy +19

Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma

Stephen M. Ansell, B K Arendt, D M Grote, +6

Leukemia

Tumor BiologyLymphoid NeoplasiaAggressive Non-hodgkinMedicineImmunology +7

MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma

Vijay Ramakrishnan, Stephen M. Ansell, Janine Haug, +8

Leukemia

Hematological MalignancyLymphoid NeoplasiaVitro Pre-clinical Activityγ-Secretase Inhibitor ExhibitsMedicine +7

A role for IFN-λ1 in multiple myeloma B cell growth

Anne J. Novak, D M Grote, Steven C. Ziesmer, +2

Leukemia

Hematological MalignancyImmunologyHematologyMedicineCell Biology +3

Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma

Stephen M. Ansell, Hui Tang, Paul J. Kurtin, +10

Leukemia

Hematological MalignancyLymphoid NeoplasiaAutoimmune DiseaseImmunologyHematology +7

MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts

Lucy S. Hodge, Sherine F. Elsawa, D M Grote, +7

Blood Cancer Journal